nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical Analysis of 21 Cases of Nongestational Ovarian Choriocarcinoma
|
Jiao, Lan-zhou |
|
|
20 |
2 |
p. 299-302 |
artikel |
2 |
Clinical Experiences on Aggressive Angiomyxoma in China (Report of 93 Cases)
|
Jingping, Zhang |
|
|
20 |
2 |
p. 303-307 |
artikel |
3 |
Coronary Heart Disease Risk Profile in Women Who Underwent Salpingo-Oophorectomy to Prevent Hereditary Breast Ovarian Cancer
|
Michelsen, Trond Melbye |
|
|
20 |
2 |
p. 233-239 |
artikel |
4 |
Diagnostic Efficacy of Real-Time Optical Coherence Tomography in the Management of Preinvasive and Invasive Neoplasia of the Uterine Cervix
|
Liu, Zhihong |
|
|
20 |
2 |
p. 283-287 |
artikel |
5 |
Differential Expression of Hypoxia-Inducible Protein 2 Among Different Histological Types of Epithelial Ovarian Cancer and in Clear Cell Adenocarcinomas
|
Nishimura, Sadako |
|
|
20 |
2 |
p. 220-226 |
artikel |
6 |
Down-Regulation of HLA Class I Antigen in Human Papillomavirus Type 16 E7 Expressing HaCaT Cells Correlate With TAP-1 Expression
|
Li, Wei |
|
|
20 |
2 |
p. 227-232 |
artikel |
7 |
Editorial
|
Beller, Uziel |
|
|
20 |
2 |
p. 195 |
artikel |
8 |
Effect of Type-Specific Human Papillomavirus Incidence on Screening Performance and Cost
|
Agorastos, Theodoros |
|
|
20 |
2 |
p. 276-282 |
artikel |
9 |
Erratum
|
|
|
|
20 |
2 |
p. 313 |
artikel |
10 |
Human Papillomavirus L1 Capsid Protein and Human Papillomavirus Type 16 as Prognostic Markers in Cervical Intraepithelial Neoplasia 1
|
Choi, Young Sam |
|
|
20 |
2 |
p. 288-293 |
artikel |
11 |
Intraperitoneal Dissemination of Endometrial Cancer Cells After Hysteroscopy
|
Polyzos, Nikolaos P. |
|
|
20 |
2 |
p. 261-267 |
artikel |
12 |
Metastatic Uterine Leiomyosarcomas
|
Bernstein-Molho, Rinat |
|
|
20 |
2 |
p. 255-260 |
artikel |
13 |
Neoadjuvant Chemotherapy in Advanced Vulvar Cancer
|
Domingues, Ana Patrícia |
|
|
20 |
2 |
p. 294-298 |
artikel |
14 |
p38α Is Required for Ovarian Cancer Cell Metabolism and Survival
|
Matrone, Antonio |
|
|
20 |
2 |
p. 203-211 |
artikel |
15 |
Prechemotherapy Serum Levels of CD105, Transforming Growth Factor β2, and Vascular Endothelial Growth Factor Are Associated With Prognosis in Patients With Advanced Epithelial Ovarian Cancer Treated With Cytoreductive Surgery and Platinum-Based Chemotherapy
|
Bozas, George |
|
|
20 |
2 |
p. 248-254 |
artikel |
16 |
Randomized Phase II Trial of Paclitaxel Plus Carboplatin Therapy Versus Irinotecan Plus Cisplatin Therapy as First-Line Chemotherapy for Clear Cell Adenocarcinoma of the Ovary
|
Takakura, Satoshi |
|
|
20 |
2 |
p. 244-251 |
artikel |
17 |
Results of Surgery After Concurrent Chemoradiotherapy in Advanced Cervical Cancer
|
Motton, Stéphanie |
|
|
20 |
2 |
p. 268-275 |
artikel |
18 |
Subcutaneous Methylnaltrexone to Restore Postoperative Bowel Function in a Long-Term Opiate User
|
Ladanyi, Andras |
|
|
20 |
2 |
p. 308-310 |
artikel |
19 |
Therapeutic Intent and Misconception in Early-Phase Clinical Trials in the Gynecologic Malignancies
|
Markman, Maurie |
|
|
20 |
2 |
p. 311-312 |
artikel |
20 |
TP53 Mutations in Endometrial Cancers
|
Janiec-Jankowska, Aneta |
|
|
20 |
2 |
p. 196-202 |
artikel |
21 |
Transcription Factor POU6F1 Is Important for Proliferation of Clear Cell Adenocarcinoma of the Ovary and Is a Potential New Molecular Target
|
Suzuki, Nao |
|
|
20 |
2 |
p. 212-219 |
artikel |